KAMAL KISHORE SHARMA

    DIN: 00209430

    For latest information about the director, visit MCA.

    KAMAL KISHORE SHARMA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 00209430. KAMAL KISHORE SHARMA is/has been associated with 23 companies.

    This is just one director. Ask about the whole track record.

    Ask Prime Research

    Companies Associated With

    Company Designation Date of Appointment
    TEMPLECRAFT REALTY LLP Designated Partner 20-Oct-2014
    TEMPLERIVIERE PROPERTY LLP Designated Partner 20-Oct-2014
    ASSETZ BUILDWELL LLP Partner 19-Aug-2015
    TEMPLE WELLNESS VENTURES LLP Designated Partner 16-Oct-2015
    SHILPA MEDICARE LIMITED Director 01-Jul-2022
    SEQUENT SCIENTIFIC LIMITED Director 17-Jan-2021
    SYMED LABS LIMITED Director 01-Dec-2022
    VIYASH LIFE SCIENCES PRIVATE LIMITED Director 01-Dec-2022
    LUPIN PHARMACARE LIMITED Director 21-Aug-2007
    FAISA FINANCIAL P LTD Director 07-Aug-1991
    TEMPLETREE PROPERTIES PRIVATE LIMITED Director 18-Jan-2006
    ALIVIRA ANIMAL HEALTH LIMITED Director 14-Sep-2020
    TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED Director 27-Apr-2017

    Past Companies Associated With

    Company Designation Date of Appointment Date of Cessation
    LUPIN LIMITED Director 29-Sep-2018 14-Oct-2022
    LUPIN LIMITED Managing Director 25-Aug-2003 01-Sep-2013
    LUPIN LIMITED Whole-time director 29-Sep-2015 29-Sep-2018
    SHILPA MEDICARE LIMITED Additional Director 01-Jul-2022 28-Sep-2022
    SEQUENT SCIENTIFIC LIMITED Additional Director 25-Aug-2020 17-Jan-2021
    LUPIN DIAGNOSTICS LIMITED Additional Director 26-Aug-2011 23-Jul-2012
    LUPIN DIAGNOSTICS LIMITED Director 23-Jul-2012 21-Nov-2022
    SYMED LABS LIMITED Additional Director 01-Dec-2022 26-Dec-2022
    VIYASH LIFE SCIENCES PRIVATE LIMITED Additional Director 01-Dec-2022 26-Dec-2022
    ALIVIRA ANIMAL HEALTH LIMITED Additional Director 09-Sep-2020 14-Sep-2020

    “Assess financial performance of all companies under a director.”

    Ask Prime Research Explore for Sales